RIMN/Tibia Nail Study
RIMN/Tibia Nail is currently in the FULL LAUNCH stage.
The β-testing sites were the following institutions: Colorado Children’s Hospital (COLORADO), Lurie Children’s Hospital (LURIE), Rady Children’s Hospital (RADY), Monroe Children’s Hospital at Vanderbilt (VANDY), and Boston Children’s Hospital (BCH) with St. Louis Children’s Hospital-Washington University (WASHU) as the lead site.
The study materials are listed below:
- RIMN Protocol: Protocol that all sites use for the study
- RIMN Data Entry Guide: Your guide to searching for patients, identifying eligible patients and conducting data entry
- RIMN PI Measurement Sheet: Will assist you in collecting data from your PIs in terms of Radiographic Measurements
- RIMN Launch Presentation: This walks you through the study, why it is being done and an overview of all the materials available to you
- RIMN Variable list: Is an overview of the variables that are being collected in the study
- Beta Launch Video: This is the recorded meeting of the beta launch; this is subject to change for the Full Launch
- PI Skeletal Maturity App Training: Training that PIs will need to complete prior to starting application measurements for the study. PIs need to send their answers to the team (Josh, Saurav, Fernanda) for approval.
For details and additional information, please reach out to the following contacts accordingly:
Admin Support & REDCap
Admin or BCH REDCap access:
cortices@childrens.harvard.edu
Data Collection & Operations
Patient search or data-entry questions:
Josh Marino
mjoshua@wustl.edu
Clinical & Medical Queries
Clinical questions requiring PI input:
Study PI: Dr. Mark Miller
mlmiller@gmail.com
Study PI: Dr. Zach Meyer
zmeyer@wustl.edu
